{"@type": "dcat:Dataset", "accessLevel": "public", "bureauCode": ["009:25"], "contactPoint": {"@type": "vcard:Contact", "fn": "NIH/NCBI Data Team", "hasEmail": "mailto:info@ncbi.nlm.nih.gov"}, "description": "This invention provides new benzoxazepine compounds represented by the formula: <CHEM> \u00c4wherein R stands for a lower alkyl group optionally substituted with a hydroxyl group, X stands for an optionally substituted carbamoyl group or an optionally substituted heterocyclic group having a deprotonatable hydrogen atom, R1 stands for a lower alkyl group and W stands for a halogen atom\u00dc having activities of lowering chlesterol-level and lowering trigluceride-level, and being useful for prophylaxis and therapy of hyperlipidemia.", "distribution": [{"@type": "dcat:Distribution", "description": "Access the complete Patent AT-E401315-T1: [Translated] 5-(2,3-DIALKOXYPHENYL)-4,1-BENZOXAZEPINE-2-ONE AS ANTI-HYPERLIPIDEMIC AGENT on the official website.", "downloadURL": "https://pubchem.ncbi.nlm.nih.gov/patent/AT-E401315-T1", "mediaType": "text/html", "title": "Official Data Source"}], "identifier": "https://healthdata.gov/api/views/6q2z-v2u6", "issued": "2025-09-05", "keyword": ["chemistry", "innovation", "patent", "pubchem", "research"], "landingPage": "https://healthdata.gov/d/6q2z-v2u6", "modified": "2025-09-06", "programCode": ["009:066"], "publisher": {"@type": "org:Organization", "name": "National Center for Biotechnology Information (NCBI)"}, "theme": ["NIH"], "title": "Patent AT-E401315-T1: [Translated] 5-(2,3-DIALKOXYPHENYL)-4,1-BENZOXAZEPINE-2-ONE AS ANTI-HYPERLIPIDEMIC AGENT"}